USM vs. LLY
Compare and contrast key facts about United States Cellular Corporation (USM) and Eli Lilly and Company (LLY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: USM or LLY.
Correlation
The correlation between USM and LLY is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
USM vs. LLY - Performance Comparison
Loading data...
Key characteristics
USM:
0.91
LLY:
-0.10
USM:
1.60
LLY:
0.18
USM:
1.21
LLY:
1.02
USM:
0.68
LLY:
-0.10
USM:
5.89
LLY:
-0.19
USM:
6.72%
LLY:
12.99%
USM:
41.82%
LLY:
38.39%
USM:
-86.23%
LLY:
-68.27%
USM:
-40.63%
LLY:
-21.76%
Fundamentals
USM:
$5.20B
LLY:
$677.89B
USM:
-$0.46
LLY:
$12.27
USM:
1.42
LLY:
1.16
USM:
1.40
LLY:
13.83
USM:
1.15
LLY:
43.13
USM:
$3.71B
LLY:
$49.00B
USM:
$2.30B
LLY:
$40.03B
USM:
$773.00M
LLY:
$16.67B
Returns By Period
In the year-to-date period, USM achieves a -2.17% return, which is significantly higher than LLY's -2.87% return. Over the past 10 years, USM has underperformed LLY with an annualized return of 4.73%, while LLY has yielded a comparatively higher 28.25% annualized return.
USM
-2.17%
-10.62%
-1.29%
37.89%
27.91%
14.97%
4.73%
LLY
-2.87%
-10.88%
2.75%
-3.97%
36.90%
39.06%
28.25%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
USM vs. LLY — Risk-Adjusted Performance Rank
USM
LLY
USM vs. LLY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for United States Cellular Corporation (USM) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
USM vs. LLY - Dividend Comparison
USM has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.75%.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
USM United States Cellular Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LLY Eli Lilly and Company | 0.75% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% | 2.84% |
Drawdowns
USM vs. LLY - Drawdown Comparison
The maximum USM drawdown since its inception was -86.23%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for USM and LLY. For additional features, visit the drawdowns tool.
Loading data...
Volatility
USM vs. LLY - Volatility Comparison
The current volatility for United States Cellular Corporation (USM) is 15.81%, while Eli Lilly and Company (LLY) has a volatility of 17.32%. This indicates that USM experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
USM vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between United States Cellular Corporation and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
USM vs. LLY - Profitability Comparison
USM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, United States Cellular Corporation reported a gross profit of 713.00M and revenue of 891.00M. Therefore, the gross margin over that period was 80.0%.
LLY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a gross profit of 10.50B and revenue of 12.73B. Therefore, the gross margin over that period was 82.5%.
USM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, United States Cellular Corporation reported an operating income of 41.00M and revenue of 891.00M, resulting in an operating margin of 4.6%.
LLY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported an operating income of 5.41B and revenue of 12.73B, resulting in an operating margin of 42.5%.
USM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, United States Cellular Corporation reported a net income of 18.00M and revenue of 891.00M, resulting in a net margin of 2.0%.
LLY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a net income of 2.76B and revenue of 12.73B, resulting in a net margin of 21.7%.